These drugs manage blood sugar levels and suppress appetite
Diabetes Obes Metab 23(9):21162124
The organizations seeing the greatest success are focusing on balanced strategies that combine thoughtful coverage design, clinical support, utilization management, and ongoing evaluation of outcomes
Understanding the risk factors can help you and your doctor make better decisions about your treatment
In addition to monitoring weight loss and nutritional statues, future clinical trials should measure nausea and emesis following activation of central GLP-1-producing circuits as these adverse effects are the main reason cited for discontinuation of GLP-1R agonist pharmacotherapy 29,39
Emerging preclinical research and patient reports suggest GLP-1 medications may influence cravings and consumption patterns for alcohol, tobacco, and other substances